GlassScriptPhysician profile
Morgan Allen
NPI 1881157667
$1,359.10
in general payments reported to CMS, 2019-2025
20 companies · $851 in 2025
The $851 reported for 2025 was more than what 84% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $45.74 · 2023: $162 · 2024: $300 · 2025: $851.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,313.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,313.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $294.50 | 2022-2025 | Ozempic, Rybelsus, Wegovy |
| Astrazeneca Pharmaceuticals LP | $193.95 | 2024-2025 | Farxiga, Airsupra, Breztri |
| Bayer Healthcare Pharmaceuticals INC. | $167.00 | 2023-2025 | |
| Lilly USA, LLC | $118.03 | 2023-2024 | Mounjaro, Zepbound, Trulicity |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $80.83 | 2025 | Xifaxan |
| Lundbeck LLC | $67.25 | 2025 | Vyepti, Rexulti |
| Glaxosmithkline, LLC. | $66.12 | 2023-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Merck Sharp & Dohme LLC | $50.15 | 2024-2025 | Capvaxive, Gardasil 9, Gardasil |
| Exact Sciences Corporation | $49.78 | 2023-2024 | Cologuard Collection Kit |
| Janssen Pharmaceuticals, INC | $37.23 | 2023 | Xarelto |
| Abbvie INC. | $32.82 | 2022-2025 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $32.53 | 2025 | Caplyta |
| Shield Therapeutics INC | $31.38 | 2024-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $28.35 | 2025 | Jardiance |
| Otsuka America Pharmaceutical, INC. | $22.52 | 2024 | Rexulti |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tactile Systems Technology INC | $20.41 | 2025 | Flexitouch Plus, Nimbl |
| Pfizer INC. | $18.64 | 2025 | |
| Novartis Pharmaceuticals Corporation | $17.69 | 2025 | |
| Medtronic, INC. | $15.45 | 2025 | Intellis Adaptivestim |
| Dexcom, INC. | $14.47 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Morgan Allen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.